Jeegar Pravinkumar Patel's most recent trade in Evommune Inc. was a trade of 1,488 Common Stock done at an average price of $22.5 . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 22 Jun 2026 | 1,488 | 46,403 | - | 22.5 | 33,480 | Common Stock |
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 22 Jun 2026 | 1,488 | 47,891 | - | 3.8 | 5,714 | Common Stock |
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | 22 Jun 2026 | 1,488 | 27,842 | - | - | Employee Stock Option (Right to Buy) | ||
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.74 per share. | 01 Jun 2026 | 16,687 | 46,403 | - | 22.7 | 379,462 | Common Stock |
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | 01 Jun 2026 | 13,512 | 29,330 | - | - | Employee Stock Option (Right to Buy) | ||
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.84 per share. | 01 Jun 2026 | 13,512 | 63,090 | - | 3.8 | 51,886 | Common Stock |
| Evommune Inc | Dr. Jeegar Pravinkumar Patel, PhD | Chief Scientific Officer | 16 Apr 2026 | 69,315 | 69,315 | - | - | Employee Stock Option (Right to Buy) | ||
| Evommune Inc | Mr. Jeegar Pravinkumar Patel | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.84 per share. | 09 Dec 2025 | 7,513 | 49,578 | - | 17.8 | 134,032 | Common Stock |
| Evommune Inc | Mr. Jeegar Pravinkumar Patel | Chief Scientific Officer | 07 Nov 2025 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Mr. Jeegar Pravinkumar Patel | Chief Scientific Officer | 07 Nov 2025 | 3,175 | 57,091 | - | - | Common Stock | ||
| Evommune Inc | Mr. Jeegar Pravinkumar Patel | Chief Scientific Officer | 05 Nov 2025 | 179,619 | 179,619 | - | - | Employee Stock Option (Right to Buy) |